184 related articles for article (PubMed ID: 35392571)
1. Therapeutic Efficacy of Intravesical Platelet-Rich Plasma Injections for Interstitial Cystitis/Bladder Pain Syndrome-A Comparative Study of Different Injection Number, Additives and Concentrations.
Jiang YH; Jhang JF; Lin TY; Ho HC; Hsu YH; Kuo HC
Front Pharmacol; 2022; 13():853776. PubMed ID: 35392571
[No Abstract] [Full Text] [Related]
2. Comparison of the Clinical Efficacy and Adverse Events between Intravesical Injections of Platelet-Rich Plasma and Botulinum Toxin A for the Treatment of Interstitial Cystitis Refractory to Conventional Treatment.
Jhang JF; Yu WR; Kuo HC
Toxins (Basel); 2023 Feb; 15(2):. PubMed ID: 36828435
[TBL] [Abstract][Full Text] [Related]
3. Repeated intravesical injections of platelet-rich plasma are effective in the treatment of interstitial cystitis: a case control pilot study.
Jhang JF; Wu SY; Lin TY; Kuo HC
Low Urin Tract Symptoms; 2019 Apr; 11(2):O42-O47. PubMed ID: 29265766
[TBL] [Abstract][Full Text] [Related]
4. Intravesical injections of platelet-rich plasma is effective and safe in treatment of interstitial cystitis refractory to conventional treatment-A prospective clinical trial.
Jhang JF; Lin TY; Kuo HC
Neurourol Urodyn; 2019 Feb; 38(2):703-709. PubMed ID: 30576011
[TBL] [Abstract][Full Text] [Related]
5. Improved Urothelial Cell Proliferation, Cytoskeleton and Barrier Function Protein Expression in the Patients With Interstitial Cystitis/Bladder Pain Syndrome After Intravesical Platelet-Rich Plasma Injection.
Jhang JF; Jiang YH; Hsu YH; Ho HC; Birder LA; Lin TY; Kuo HC
Int Neurourol J; 2022 Feb; 26(Suppl 1):S57-67. PubMed ID: 35073671
[TBL] [Abstract][Full Text] [Related]
6. Repeated intravesical onabotulinumtoxinA injections are effective in treatment of refractory interstitial cystitis/bladder pain syndrome.
Kuo HC
Int J Clin Pract; 2013 May; 67(5):427-34. PubMed ID: 23574103
[TBL] [Abstract][Full Text] [Related]
7. Repeated intravesical injections of platelet-rich plasma improve symptoms and alter urinary functional proteins in patients with refractory interstitial cystitis.
Jiang YH; Kuo YC; Jhang JF; Lee CL; Hsu YH; Ho HC; Kuo HC
Sci Rep; 2020 Sep; 10(1):15218. PubMed ID: 32939046
[TBL] [Abstract][Full Text] [Related]
8. Changes in the Ultrastructure of the Bladder Urothelium in Patients with Interstitial Cystitis after Intravesical Injections of Platelet-Rich Plasma.
Lee YK; Jiang YH; Jhang JF; Ho HC; Kuo HC
Biomedicines; 2022 May; 10(5):. PubMed ID: 35625918
[TBL] [Abstract][Full Text] [Related]
9. Intravesical botulinum toxin a injections do not benefit patients with ulcer type interstitial cystitis.
Lee CL; Kuo HC
Pain Physician; 2013; 16(2):109-16. PubMed ID: 23511677
[TBL] [Abstract][Full Text] [Related]
10. Use of Intravesical Injections of Platelet-Rich Plasma for the Treatment of Bladder Pain Syndrome: A Comprehensive Literature Review.
Trama F; Illiano E; Marchesi A; Brancorsini S; Crocetto F; Pandolfo SD; Zucchi A; Costantini E
Antibiotics (Basel); 2021 Oct; 10(10):. PubMed ID: 34680774
[TBL] [Abstract][Full Text] [Related]
11. Sexual dysfunction in women with interstitial cystitis/bladder pain syndrome: Do onabotulinum toxin-A injections improve sexual function?
Topcuoglu M; Karaburun MC; İbiş A; Gokce Mİ; Süer E; Gülpinar O
Neurourol Urodyn; 2023 Mar; 42(3):607-614. PubMed ID: 36708358
[TBL] [Abstract][Full Text] [Related]
12. Amniotic bladder therapy: six-month follow up treating interstitial cystitis/bladder pain syndrome.
Considine J; O'Hollaren K; Radoiu C; Madan R; Liaw A; Dhar N
Can J Urol; 2024 Jun; 31(3):11898-11903. PubMed ID: 38912944
[TBL] [Abstract][Full Text] [Related]
13. The effect of intravesical hyaluronic acid therapy on urodynamic and clinical outcomes among women with interstitial cystitis/bladder pain syndrome.
Peng YC; Yueh-Hsia Chiu S; Feng M; Liang CC
Taiwan J Obstet Gynecol; 2020 Nov; 59(6):922-926. PubMed ID: 33218413
[TBL] [Abstract][Full Text] [Related]
14. Hyaluronic acid improves pain symptoms more than bladder storage symptoms in women with interstitial cystitis.
Hung MJ; Tsai CP; Lin YH; Huang WC; Chen GD; Shen PS
Taiwan J Obstet Gynecol; 2019 May; 58(3):417-422. PubMed ID: 31122535
[TBL] [Abstract][Full Text] [Related]
15. Changes in sexual function of women with refractory interstitial cystitis/bladder pain syndrome after intravesical therapy with a hyaluronic acid solution.
Hung MJ; Su TH; Lin YH; Huang WC; Lin TY; Hsu CS; Chuang FC; Tsai CP; Shen PS; Chen GD
J Sex Med; 2014 Sep; 11(9):2256-63. PubMed ID: 24636240
[TBL] [Abstract][Full Text] [Related]
16. Long-Term Efficacy and Safety of Repeated Intravescial OnabotulinumtoxinA Injections Plus Hydrodistention in the Treatment of Interstitial Cystitis/Bladder Pain Syndrome.
Lee CL; Kuo HC
Toxins (Basel); 2015 Oct; 7(10):4283-93. PubMed ID: 26506388
[TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical evidence suggests repeated intravesical application of botulinum toxin A injections may improve treatment efficacy of interstitial cystitis/bladder pain syndrome.
Shie JH; Liu HT; Wang YS; Kuo HC
BJU Int; 2013 Apr; 111(4):638-46. PubMed ID: 22943596
[TBL] [Abstract][Full Text] [Related]
18. O'Leary-Sant Symptom Index Predicts the Treatment Outcome for OnabotulinumtoxinA Injections for Refractory Interstitial Cystitis/Bladder Pain Syndrome.
Kuo YC; Kuo HC
Toxins (Basel); 2015 Jul; 7(8):2860-71. PubMed ID: 26264022
[TBL] [Abstract][Full Text] [Related]
19. Intravesical onabotulinumtoxinA injections for refractory painful bladder syndrome.
Chung SD; Kuo YC; Kuo HC
Pain Physician; 2012; 15(3):197-202. PubMed ID: 22622903
[TBL] [Abstract][Full Text] [Related]
20. Comparative study of efficacy and safety between bladder body and trigonal intravesical onabotulinumtoxina injection in the treatment of interstitial cystitis refractory to conventional treatment-A prospective, randomized, clinical trial.
Jiang YH; Jhang JF; Lee CL; Kuo HC
Neurourol Urodyn; 2018 Apr; 37(4):1467-1473. PubMed ID: 29331031
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
